List of Pherecydes Pharma patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10077431 Phage therapy of pseudomonas infections	Patent 10077431 was granted and assigned to Pherecydes Pharma on September, 2018 by the United States Patent and Trademark Office.	Pherecydes Pharma	Pherecydes Pharma	United States Patent and Trademark Office	10077431	September 18, 2018
‌ US Patent 10898530 Phage therapy	Patent 10898530 was granted and assigned to Pherecydes Pharma on January, 2021 by the United States Patent and Trademark Office.	Pherecydes Pharma	Pherecydes Pharma	United States Patent and Trademark Office	10898530	January 26, 2021
‌ US Patent 10918680 Phage therapy of	Patent 10918680 was granted and assigned to Pherecydes Pharma on February, 2021 by the United States Patent and Trademark Office.	Pherecydes Pharma	Pherecydes Pharma	United States Patent and Trademark Office	10918680	February 16, 2021
‌ US Patent 10260051 Phage therapy of	Patent 10260051 was granted and assigned to Pherecydes Pharma on April, 2019 by the United States Patent and Trademark Office.	Pherecydes Pharma	Pherecydes Pharma	United States Patent and Trademark Office	10260051	April 16, 2019
‌ US Patent 9029153 Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof	Patent 9029153 was granted and assigned to Pherecydes Pharma on May, 2015 by the United States Patent and Trademark Office.		Pherecydes Pharma	United States Patent and Trademark Office	9029153	May 12, 2015
‌ US Patent 11779617 Phage therapy	Patent 11779617 was granted and assigned to Pherecydes Pharma on October, 2023 by the United States Patent and Trademark Office.	Pherecydes Pharma	Pherecydes Pharma	United States Patent and Trademark Office	11779617	October 10, 2023
‌ US Patent 11690885 Anti-bacterial compositions and uses thereof		Pherecydes Pharma	Pherecydes Pharma	United States Patent and Trademark Office	11690885	July 4, 2023